Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
21.31
-0.01 (-0.05%)
At close: Dec 9, 2025, 4:00 PM EST
21.37
+0.06 (0.28%)
After-hours: Dec 9, 2025, 7:20 PM EST
Avadel Pharmaceuticals Market Cap
Avadel Pharmaceuticals has a market cap or net worth of $2.09 billion as of December 9, 2025. Its market cap has increased by 101.58% in one year.
Market Cap
2.09B
Enterprise Value
2.03B
1-Year Change
101.58%
Ranking
Category
Stock Price
$21.31
Market Cap Chart
Since April 15, 2024, Avadel Pharmaceuticals's market cap has increased from $1.54B to $2.09B, an increase of 35.61%. That is a compound annual growth rate of 20.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 2.09B | 106.28% |
| Dec 31, 2024 | 1.01B | -34.23% |
| Apr 15, 2024 | 1.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |